Beatrix Hoffman, Nancy Tomes, Rachel Grob and Mark Schlesinger (eds), Patients as Policy Actors
Abstract
Over the last 40 years patients have become more visible in health policy and practice, yet they seem to wield little effective power. Major changes to health systems in countries around the world (including both the USA and the UK) have been introduced in the name of the patient, but the role played by patient organisations in such developments has often been marginal. In Patients as Policy Actors, Beatrix Hoffman, Nancy Tomes, Rachel Grob and Mark Schlesinger attempt to explain this enigma, and by bringing together the work of a diverse group of authors, they expose the varied ways in which patients have had an impact in the health arena. Contributions from historians, sociologists, psychologists, political scientists, journalists, lawyers and economists highlight the multiplicity of patient activism in a range of settings. Such an inter-disciplinary approach works well with a topic that spills over into many different fields of interest, and there is much of value here for historians and social scientists alike.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.